|Medicare and Tivicay
Jan 15, 2014
It doesn't appear that Medicare currently covers Tivicay (dolutegravir). Is there any way to find out why that's the case? Could it be that it's simply working its way through some lengthy approval process or has Medicare already evaluated this medication and decided not to cover it? The latter possibility seems odd given how quickly after the FDA gave approval in 2012 to Stribild that Medicare included it in its formulary. Oddly, but thankfully, Tivicay is included in the ADAP formulary in such diverse states as California, Florida, Ohio and Arkansas.
Response from Mr. Chambers
The prescription medications under Medicare Part D are handled by private insurance companies. Each carrier creates its own formulary within the overall guidelines.
Medicare Part D plans are required to cover "all or substantially all" drugs in six specified classes, including antiretrovirals, however, it may be too new for your plan to have added it yet.
You should contact the carrier that handles your Part D coverage and see when they plan to add Tivicay. Also ask what procedure they have so your doctor can apply for an exception to get it covered while waiting for it to be added to their formulary.
- Are Sore Testicles A Symptom Of HIV?
- Dry Cough Sign Of Seroconversion
- Burning Penis After Unprotected Anal Sex Without Ejaculation Does It Mean I Have HIV
- White Discharge After Vaginal Sex With Condom Does It Mean I Have HIV
- Can Penicillin Cure Gonorrhea?
- 100 Day Negative Hiv Rapid Test
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.